Cranial neural crest cell contribution to craniofacial formation, pathology, and future directions in tissue engineering

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 102, Issue 3, 2014, Pages 324-332

  Snider, Taylor Nicholas ^a   Mishina, Yuji ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

Cranial neural crest cell; Craniofacial abnormality; Gene regulatory networks; Tissue engineering

Indexed keywords

ANIMAL; CELL DIFFERENTIATION; CELL MOTION; CRANIOSYNOSTOSES; CYTOLOGY; DISEASE MODEL; EMBRYOLOGY; GENE REGULATORY NETWORK; HUMAN; NEURAL CREST; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TISSUE ENGINEERING; VERTEBRATE;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CRANIOSYNOSTOSES; DISEASE MODELS, ANIMAL; GENE REGULATORY NETWORKS; HUMANS; NEURAL CREST; TISSUE ENGINEERING; VERTEBRATES;

EID: 84908499252     PISSN: 1542975X     EISSN: 15429768     Source Type: Journal    
DOI: 10.1002/bdrc.21075     Document Type: Article

References (52)

1. Achilleos A, Trainor PA. 2012. Neural crest stem cells: discovery, properties and potential for therapy. Cell Res 22:288-304.
2. Ashokan CS, Sreenivasan A, Saraswathy GK. 2014. Goldenhar syndrome-review with case series. J Clin Diagn Res 8:ZD17-ZD19.
3. Bassett AS, McDonald-McGinn DM, Devriendt K, et al. 2011. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr 159:332-339.
4. Boutros S, Shetye PR, Ghali S, et al. 2007. Morphology and growth of the mandible in Crouzon, Apert, and Pfeiffer syndromes. J Craniofac Surg 18:146-150.
5. Burstyn-Cohen T, Stanleigh J, Sela-Donenfeld D, Kalcheim C. 2004. Canonical Wnt activity regulates trunk neural crest delamination linking BMP/noggin signaling with G1/S transition. Development 131:5327-5339.
6. Cooper GM, Durham EL, Cray JJ Jr, et al. 2012. Tissue interactions between craniosynostotic dura mater and bone. J Craniofac Surg 23:919-924.
7. Creuzet S, Schuler B, Couly G, Le Douarin NM. 2004. Reciprocal relationships between Fgf8 and neural crest cells in facial and forebrain development. Proc Natl Acad Sci USA 101:4843-4847.
8. Dixon J, Jones NC, Sandell LL, et al. 2006. Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities. Proc Natl Acad Sci USA 103:13403-13408.
9. Dudas M, Kim J, Li WY, et al. 2006. Epithelial and ectomesenchymal role of the type I TGF-beta receptor ALK5 during facial morphogenesis and palatal fusion. Dev Biol 296:298-314.
10. Ezaldein HH, Metzler P, Persing JA, Steinbacher DM. 2014. Three-dimensional orbital dysmorphology in metopic synostosis. J Plast Reconstr Aesthet Surg 67:900-905.
11. Graham A, Francis-West P, Brickell P, Lumsden A. 1994. The signalling molecule BMP4 mediates apoptosis in the rhombencephalic neural crest. Nature 372:684-686.
12. Green SA, Bronner ME. 2014. The lamprey: a jawless vertebrate model system for examining origin of the neural crest and other vertebrate traits. Differentiation 87:44-51.
13. Hou L, Pavan WJ. 2008. Transcriptional and signaling regulation in neural crest stem cell-derived melanocyte development: do all roads lead to Mitf? Cell Res 18:1163-1176.
14. Hsu PD, Lander ES, Zhang F. 2014. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157:1262-1278.
15. Huang CY, Pelaez D, Dominguez-Bendala J, et al. 2009. Plasticity of stem cells derived from adult periodontal ligament. Regen Med 4:809-821.
16. Ibrahimi OA, Zhang F, Eliseenkova AV, et al. 2004. Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Hum Mol Genet 13:69-78.
17. Ishii M, Arias AC, Liu L, et al. 2012. A stable cranial neural crest cell line from mouse. Stem Cells Dev 21:3069-3080.
18. Ito Y, Yeo JY, Chytil A, et al. 2003. Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects. Development 130:5269-5280.
19. Jabs EW, Li X, Scott AF, et al. 1994. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet 8:275-279.
20. Jones NC, Lynn ML, Gaudenz K, et al. 2008. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat Med 14:125-133.
21. Kaartinen V, Voncken JW, Shuler C, et al. 1995. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11:415-421.
22. Lalani SR, Safiullah AM, Fernbach SD, et al. 2006. Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am J Hum Genet 78:303-314.
23. Le Douarin N. 1973. A biological cell labeling technique and its use in expermental embryology. Dev Biol 30:217-222.
24. Le Douarin N, Kalcheim C. 1999. The neural crest. Cambridge, UK: Cambridge University Press.
25. Loeys BL, Chen J, Neptune ER, et al. 2005. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37:275-281.
26. Matera I, Watkins-Chow DE, Loftus SK, et al. 2008. A sensitized mutagenesis screen identifies Gli3 as a modifier of Sox10 neurocristopathy. Hum Mol Genet 17:2118-2131.
27. Minoux M, Kratochwil CF, Ducret S, et al. 2013. Mouse Hoxa2 mutations provide a model for microtia and auricle duplication. Development 140:4386-4397.
28. Mishina Y, Snider TN. 2014. Neural crest cell signaling pathways critical to cranial bone development and pathology. Exp Cell Res 325:138-147.
29. Miura M, Gronthos S, Zhao M, et al. 2003. SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA 100:5807-5812.
30. Nagashima H, Shibata M, Taniguchi M, et al. 2014. Comparative study of the shell development of hard- and soft-shelled turtles. J Anat 225:60-70.
31. Noden DM, Trainor PA. 2005. Relations and interactions between cranial mesoderm and neural crest populations. J Anat 207:575-601.
32. Papangeli I, Scambler P. 2013. The 22q11 deletion: DiGeorge and velocardiofacial syndromes and the role of TBX1. Wiley Interdiscip Rev Dev Biol 2:393-403.
33. Pelaez D, Huang CY, Cheung HS. 2013. Isolation of pluripotent neural crest-derived stem cells from adult human tissues by connexin-43 enrichment. Stem Cells Dev 22:2906-2914.
34. Perez-Alcala S, Nieto MA, Barbas JA. 2004. LSox5 regulates RhoB expression in the neural tube and promotes generation of the neural crest. Development 131:4455-4465.
35. Pingault V, Ente D, Dastot-Le Moal F, et al. 2010. Review and update of mutations causing Waardenburg syndrome. Hum Mutat 31:391-406.
36. Reardon W, Winter RM, Rutland P, et al. 1994. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 8:98-103.
37. Rinon A, Molchadsky A, Nathan E, et al. 2011. p53 coordinates cranial neural crest cell growth and epithelial-mesenchymal transition/delamination processes. Development 138:1827-1838.
38. Rogers CD, Saxena A, Bronner ME. 2013. Sip1 mediates an E-cadherin-to-N-cadherin switch during cranial neural crest EMT. J Cell Biol 203:835-847.
39. Roscioli T, Elakis G, Cox TC, et al. 2013. Genotype and clinical care correlations in craniosynostosis: findings from a cohort of 630 Australian and New Zealand patients. Am J Med Genet C Semin Med Genet 163C:259-270.
40. Sanger C, David L, Argenta L. 2014. Latest trends in minimally invasive synostosis surgery: a review. Curr Opin Otolaryngol Head Neck Surg 22:316-321.
41. Santagati F, Rijli FM. 2003. Cranial neural crest and the building of the vertebrate head. Nat Rev Neurosci 4:806-818.
42. Shprintzen RJ, Goldberg RB, Lewin ML, et al. 1978. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J 15:56-62.
43. Simoes-Costa M, Tan-Cabugao J, Antoshechkin I, et al. 2014. Transcriptome analysis reveals novel players in the cranial neural crest gene regulatory network. Genome Res 24:281-290.
44. Southard-Smith EM, Angrist M, Ellison JS, et al. 1999. The Sox10(Dom) mouse: modeling the genetic variation of Waardenburg-Shah (WS4) syndrome. Genome Res 9:215-225.
45. Takahashi K, Nuckolls GH, Takahashi I, et al. 2001. Msx2 is a repressor of chondrogenic differentiation in migratory cranial neural crest cells. Dev Dyn 222:252-262.
46. Theveneau E, Mayor R. 2012. Neural crest migration: interplay between chemorepellents, chemoattractants, contact inhibition, epithelial-mesenchymal transition, and collective cell migration. Wiley Interdiscip Rev Dev Biol 1:435-445.
47. Theveneau E, Duband JL, Altabef M. 2007. Ets-1 confers cranial features on neural crest delamination. PLoS One 2:e1142.
48. Trainor P. 2013. Neural crest cells: evolution, development and disease. In: Trainor P, editor. London, UK: Academic Press. p. 488.
49. Wang Y, Cox MK, Coricor G, et al. 2013. Inactivation of Tgfbr2 in Osterix-Cre expressing dental mesenchyme disrupts molar root formation. Dev Biol 382:27-37.
50. Winograd J, Reilly MP, Roe R, et al. 1997. Perinatal lethality and multiple craniofacial malformations in MSX2 transgenic mice. Hum Mol Genet 6:369-379.
51. Xu X, Chen C, Akiyama K, et al. 2013. Gingivae contain neural-crest- and mesoderm-derived mesenchymal stem cells. J Dent Res 92:825-832.
52. Young NM, Hu D, Lainoff AJ, et al. 2014. Embryonic bauplans and the developmental origins of facial diversity and constraint. Development 141:1059-1063.